The GST Council has reduced the tax rate on specific cancer drugs and helicopter travel on a ‘seat-share basis’ to 5%, while lowering the levy on namkeen from 18% to 12%. It also agreed to exempt R&D funded by private and public sources from GST. Discussions on health insurance tax reductions were deferred.
Related Posts
Sovereign Gold Bonds: How investors can buy SGBs from the stock market; step-by-step guide
The government introduced Sovereign Gold Bonds (SGBs) in 2015 as a safer alternative to physical gold. They can be bought during subscription periods or from […]
IT companies appraisal, hike cycles shift from June to September quarter
Salary increases in IT companies have shifted from the traditional April-June period to later in the year, influenced by fluctuating demand. This shift has led […]
Retail CPI inflation eases to 7-month low of 3.61% in February; January IIP growth at 5%
- staff
- March 12, 2025
- 0
Retail inflation in February dropped to a 7-month low of 3.61%. It remains within the RBI’s target. Food inflation also saw significant reductions in both […]